Quality of care improved more for low sociodemographic groups than higher ones under a value-based provider contract in Massachusetts.
Read More
A report from the Berkeley Research Group analyzes what proportion of total revenue various parties in the prescription drug manufacturing and distribution chain receive.
Read More
A study from the Blue Cross Blue Shield association finds that retail clinic use among their plans is increasing.
Read More
People with mental health conditions tend to have a lot of other health spending, and vice versa, according to research carried in Health Affairs.
Read More
Merck has released showing that it had a net 5.5% unit price increase across all its drugs in 2016. It is acting like it is some kind of a hero for its transparency. This is disgraceful, that increase in far above general inflation and personal income growth. It also makes no sense, because Merck's costs for the drug are undoubtedly going down. So should prices. The drug companies are inevitably going to get what they deserve for avaricious behavior.
http://www.wsj.com/articles/merck-reveals-details-on-u-s-drug-pricing-practices-1485518403I wouldn't normally mention this one, but too good to pass up, Asian hospital search app develop B-Bros raises a fresh 9 billion won (I think that is 37 cents after currency translation, no, its really around $7 million) for its app called "Ddocdoc". Iii Lovelovelove Ititit.
http://www.venturesquare.net/world/ddocdoc-additional-seriesb-investment/The year-end report from the National Venture Capital Association finds that 2016 was not as vigorous as earlier years in some respects, but still had a high level of venture…
Read More